Effectiveness of Triamcinolone Acetonide Ointment and Bovine Basic Fibroblast Growth Factor in the Treatment of Minor Recurrent Aphthous Ulcer
Muhammad Amin Karim, Ashfaq Ahmad Shah Bukhari, Farooq Khan, Rizwan Faisal, Umair Wadood, Ulfat Sultana
780
ABSTRACT
Aim: To
compare the efficacy
of triamcinolone acetonide ointment and bovine basic fibroblast growth factor
in the treatment of minor recurrent aphthous ulcer.
Study Design: Comparative study
Place & Duration: Deptt of Medicine, Rehman Medical College Peshawar
from 1st August 2018 to 31st July 2019.
Methodology: Fifty
patients were included in the study. Patients were randomly divided into 2
groups, each containing 25 patients. Group A was treated with 0.1%
triamcinolone acetonide oral ointment (5 g/tube, once a day), while group B was
treated with recombinant bovine basic fibroblast growth factor (21000IU/5g/tube, three times a day). Patients in the two groups
were compared on the basis of visual analog score, time of target ulcer pain
relief, target ulcer area index, target ulcer exudation and hyperemia score on
1st, 3rd, 5th and 7thday of visit.
Results: The
healing time of target ulcer in group A and group B was 4.40±1.09 and 6.09±1.50
days respectively, with statistically significant difference (p<0.0001). The
onset time of target ulcer analgesia in group A was shorter than that in group
B, with statistically significant difference (p<0.001). Visual analog score of group A
on day 3 and 7 were significantly improved than group B with p<0.05 each while
insignificant differences were found on day 5. On day 3, the target ulcer area
index of group A was significantly better than group B (p=0.003). On day 5, the exudation and hyperemia
score of group A were improved than group B, with statistically significant
difference (p<0.05 each).
Conclusion: Triamcinolone
acetonide oral ointment is more effective than basic fibroblast growth factor
in the treatment of minor recurrent aphthous ulcer.
Keyword: Triamcinolone
acetonide, Aphthous ulcer, basic fibroblast growth
factor.